183 related articles for article (PubMed ID: 23047567)
1. Iodine isotope ¹³¹I therapy for toxic nodular goitre: treatment efficacy parameters.
Szumowski P; Rogowski F; Abdelrazek S; Kociura-Sawicka A; Sokolik-Ostasz A
Nucl Med Rev Cent East Eur; 2012 Apr; 15(1):7-13. PubMed ID: 23047567
[TBL] [Abstract][Full Text] [Related]
2. Radioiodine treatment of hyperthyroidism in patients with low thyroid uptake.
Ruchała M; Sowiński J; Dolata M; Junik R; Gembicki M; Skiba A
Nucl Med Rev Cent East Eur; 2005; 8(1):28-32. PubMed ID: 15977144
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of factors affecting treatment results for toxic goiter with radioactive 131I].
Listewnik MH
Ann Acad Med Stetin; 2000; 46():109-21. PubMed ID: 11712298
[TBL] [Abstract][Full Text] [Related]
4. Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres.
Silva MN; Rubió IG; Romão R; Gebrin EM; Buchpiguel C; Tomimori E; Camargo R; Cardia MS; Medeiros-Neto G
Clin Endocrinol (Oxf); 2004 Mar; 60(3):300-8. PubMed ID: 15008994
[TBL] [Abstract][Full Text] [Related]
5. Dose selection for radioiodine therapy of borderline hyperthyroid patients with multifocal and disseminated autonomy on the basis of 99mTc-pertechnetate thyroid uptake.
Reinhardt MJ; Joe A; von Mallek D; Zimmerlin M; Manka-Waluch A; Palmedo H; Krause TM
Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):480-5. PubMed ID: 11914885
[TBL] [Abstract][Full Text] [Related]
6. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
[TBL] [Abstract][Full Text] [Related]
7. Serum TSH and the response to radioiodine treatment of toxic multinodular goitre.
Pedersen-Bjergaard U; Kirkegaard C
Eur J Endocrinol; 1997 Oct; 137(4):365-9. PubMed ID: 9368504
[TBL] [Abstract][Full Text] [Related]
8. Determinants of longterm outcome of radioiodine therapy of sporadic non-toxic goitre.
Le Moli R; Wesche MF; Tiel-Van Buul MM; Wiersinga WM
Clin Endocrinol (Oxf); 1999 Jun; 50(6):783-9. PubMed ID: 10468951
[TBL] [Abstract][Full Text] [Related]
9. Radioiodine therapy in non-toxic multinodular goitre. The possibility of effect-amplification with recombinant human TSH (rhTSH).
Bonnema SJ; Nielsen VE; Hegedüs L
Acta Oncol; 2006; 45(8):1051-8. PubMed ID: 17118838
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human thyrotropin stimulation prior to
Azorín Belda MJ; Martínez Caballero A; Figueroa Ardila GC; Martínez Ramírez M; Gómez Jaramillo CA; Dolado Ardit JI; Verdú Rico J
Rev Esp Med Nucl Imagen Mol; 2017; 36(1):7-12. PubMed ID: 27422154
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
Bakker SC; Zanin DE; Zweers EJ
Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
[TBL] [Abstract][Full Text] [Related]
12. The influence of non-radioactive iodine (127I) on the outcome of radioiodine (131I) therapy in patients with Graves' disease and toxic nodular goitre.
Rogowski F; Abdelrazek S; Szumowski P; Zonenberg A; Parfienczyk A; Sawicka A
Nucl Med Rev Cent East Eur; 2011; 14(1):9-15. PubMed ID: 21751166
[TBL] [Abstract][Full Text] [Related]
13. Outcome of radioiodine-131 therapy in hyperfunctioning thyroid nodules: a 20 years' retrospective study.
Ceccarelli C; Bencivelli W; Vitti P; Grasso L; Pinchera A
Clin Endocrinol (Oxf); 2005 Mar; 62(3):331-5. PubMed ID: 15730415
[TBL] [Abstract][Full Text] [Related]
14. Radioiodine and percutaneous ethanol injection in the treatment of large toxic thyroid nodule: a long-term study.
Zingrillo M; Torlontano M; Ghiggi MR; Frusciante V; Varraso A; Liuzzi A; Trischitta V
Thyroid; 2000 Nov; 10(11):985-9. PubMed ID: 11128727
[TBL] [Abstract][Full Text] [Related]
15. [The treatment of multinodular large non-toxic goiter using repeated doses of radioiodine (preliminary report)].
Pisarek M; Baczyk M; Gryczyńska M; Sowiński J
Endokrynol Pol; 2007; 58(1):18-26. PubMed ID: 17354201
[TBL] [Abstract][Full Text] [Related]
16. [The efficacy of the radioiodine treatment of toxic thyroid adenoma and multinodular goiter].
Gómez-Arnaiz N; Maravall J; Gómez JM; Gumà A; Andía E; Mora J
Rev Clin Esp; 1999 Oct; 199(10):637-40. PubMed ID: 10589246
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of thyroid scintigraphies after 131I therapy of solitary autonomous thyroid nodules.
Nygaard B; Jarløv AE; Hegedüs L; Schaadt B; Kristensen LO; Hansen JM
Thyroid; 1994; 4(2):167-71. PubMed ID: 7522683
[TBL] [Abstract][Full Text] [Related]
18. Standard dose 131I therapy for hyperthyroidism caused by autonomously functioning thyroid nodules.
Ng Tang Fui SC; Maisey MN
Clin Endocrinol (Oxf); 1979 Jan; 10(1):69-77. PubMed ID: 436306
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
[TBL] [Abstract][Full Text] [Related]
20. Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by 131I therapy.
Nygaard B; Faber J; Veje A; Hegedüs L; Hansen JM
Thyroid; 1999 May; 9(5):477-81. PubMed ID: 10365679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
